Industries > Pharma > Acute Kidney Injury Treatment Market Report to 2031
Acute Kidney Injury Treatment Market Report to 2031
Forecasts By Product (Dialysis (Intermittent Hemodialysis, Continuous Renal Replacement Therapy (CRRT), Sustained low-efficiency Dialysis (SLED)), Drug Therapy (Antibiotics, Diuretics, and Immunosuppressive Agents) By Injury (Pre-renal Injury, Intrinsic Renal Injury, and Post-renal Injury), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, and Others) PLUS COVID-19 Recovery Scenarios
Acute Kidney Injury Treatment Market – our new study reveals trends, R&D progress, and predicted revenues
Where is the Acute Kidney Injury Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Acute Kidney Injury Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Acute Kidney Injury Treatment Market: By Product
• Dialysis
o Intermittent Hemodialysis
o Continuous Renal Replacement Therapy (CRRT)
o Sustained Low Efficiency Dialysis (SLED)
• Drug Therapy
o Antibiotics
o Diuretics
o Immunosuppressive Agents
Acute Kidney Injury Treatment Market: By Injury
• Pre-renal Injury
• Intrinsic Renal Injury
• Post-renal Injury
Acute Kidney Injury Treatment Market: By Distribution Channel
• Hospitals
• Ambulatory Surgical Centers
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Acute Kidney Injury Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Acute Kidney Injury Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Acute Kidney Injury Treatment Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Acute Kidney Injury Treatment Market, with forecasts for Product, Injury, and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Acute Kidney Injury Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Acute Kidney Injury Treatment Market. Some of the company’s profiled in this report include Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem Ltd., and Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG, Exponential Biotherapies, Inc., NIKKISO AMERICA, INC., RenalGuard Solutions, Inc., Thrasos Therapeutics Inc., AtoxBio, and Sentien Biotechnologies, Inc.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Acute Kidney Injury Treatment Market Report to 2031: Forecasts By Product (Dialysis (Intermittent Hemodialysis, Continuous Renal Replacement Therapy (CRRT), Sustained low-efficiency Dialysis (SLED)), Drug Therapy (Antibiotics, Diuretics, and Immunosuppressive Agents) By Injury (Pre-renal Injury, Intrinsic Renal Injury, and Post-renal Injury), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, and Others) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Acute Kidney Injury Treatment Market
2.1. Acute Kidney Injury Treatment Market Definition
2.2. Product Submarkets Definitions
2.3. Injury Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Acute Kidney Injury Treatment Market Overview
3.1. Global Acute Kidney Injury Treatment Market Size and Forecast by Region
3.2. Global Acute Kidney Injury Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Wider availability of Treatment
3.3.1.2. Increasing the pharmaceutical industry
3.3.1.3. Rapidly increasing health care expenditure
3.3.1.4. Advancement in production techniques
3.3.2. Market Restraints/Challenges
3.3.2.1. High Competition
3.3.2.2. High Cost
3.3.3. Opportunities
3.3.3.1. Promising emerging economies
3.3.3.2. Exploring new disease Injury Types
3.3.4. Global Acute Kidney Injury Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Acute Kidney Injury Treatment Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Dialysis
4.1.1.1. Intermittent Hemodialysis
4.1.1.2. Continuous Renal Replacement Therapy (CRRT)
4.1.1.3. Sustained Low-Efficiency Dialysis (SLED)
4.1.2. Drug Therapy
4.1.2.1. Antibiotics
4.1.2.2. Diuretics
4.1.2.3. Immunosuppressive Agents
5. Global Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 by Injury (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Pre-renal Injury
5.1.2. Intrinsic Renal Injury
5.1.3. Post-renal Injury
5.1.4. Others
6. Global Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Other Distribution Channel
7. North America Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Acute Kidney Injury Treatment Market Size and Forecast by Product
7.3. North America Acute Kidney Injury Treatment Market Size and Forecast by Injury
7.4. North America Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
7.5. U.S. Acute Kidney Injury Treatment Market
7.6. Canada Acute Kidney Injury Treatment Market
8. Europe Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Acute Kidney Injury Treatment Market Size and Forecast by Product
8.3. Europe Acute Kidney Injury Treatment Market Size and Forecast by Injury
8.4. Europe Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
8.5. UK Acute Kidney Injury Treatment Market
8.6. Germany Acute Kidney Injury Treatment Market
8.7. France Acute Kidney Injury Treatment Market
8.8. Rest of Europe Acute Kidney Injury Treatment Market
9. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Product
9.3. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Injury
9.4. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
9.5. China Acute Kidney Injury Treatment Market
9.6. India Acute Kidney Injury Treatment Market
9.7. Japan Acute Kidney Injury Treatment Market
9.8. Rest of Asia Pacific Acute Kidney Injury Treatment Market
10. Latin America Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Product
10.3. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Injury
10.4. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
10.4.1. Brazil Acute Kidney Injury Treatment Market
10.4.2. Mexico Acute Kidney Injury Treatment Market
10.4.3. Rest of Latin America Acute Kidney Injury Treatment Market
11. MEA Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Acute Kidney Injury Treatment Market Size and Forecast by Product
11.3. MEA Acute Kidney Injury Treatment Market Size and Forecast by Injury
11.4. MEA Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
11.5. GCC Acute Kidney Injury Treatment Market
11.6. South Africa Acute Kidney Injury Treatment Market
11.7. Rest of MEA Acute Kidney Injury Treatment Market
12. Companies in the Acute Kidney Injury Treatment Market
12.1. Angion Biomedica Corp
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. AM-Pharma
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Quark Pharmaceuticals, Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Baxter International, Inc.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Fresenius Medical Care AG & Co. KGaA
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. LG Chem Ltd.
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Asahi Kasei Medical Co., Ltd
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. B. Braun Melsungen AG
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Exponential Biotherapies, Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. NIKKISO AMERICA, INC.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Injury
LIST OF TABLES
Table 1 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Acute Kidney Injury Treatment Market Drivers & Restraints 2020
Table 7 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227 Leading 10 Acute Kidney Injury Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 228 Angion Biomedica Corp Profile 2019 (CEO, HQ, Founded, Website)
Table 229 Angion Biomedica Corp Acute Kidney Injury Treatment Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 230 Angion Biomedica Corp Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 231 AM-Pharma Profile 2019 (CEO, HQ, Founded, Website)
Table 232 AM-Pharma Acute Kidney Injury Treatment Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 233 AM-Pharma Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 234 Quark Pharmaceuticals, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 235 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 236 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 237 Baxter International, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Baxter International, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 239 Baxter International, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 240 Fresenius Medical Care AG & Co. KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 242 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 243 LG Chem Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 244 LG Chem Ltd. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 245 LG Chem Ltd. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 246 Asahi Kasei Medical Co., Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 248 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 249 Asahi Kasei Medical Co., Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 250 B. Braun Melsungen AG Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 251 B. Braun Melsungen AG Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 252 Exponential Biotherapies, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Exponential Biotherapies, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 254 Exponential Biotherapies, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 255 NIKKISO AMERICA, INC. Profile 2019 (CEO, HQ, Founded, Website)
Table 256 NIKKISO AMERICA, INC. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 257 NIKKISO AMERICA, INC. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 258 Other Companies Involved in the Acute Kidney Injury Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Acute Kidney Injury Treatment Market Product Overview
Figure 2 Acute Kidney Injury Treatment Market Delivery Mode Overview
Figure 3 Acute Kidney Injury Treatment Market End User Overview
Figure 4 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before
Figure 35 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Acute Kidney Injury Treatment Market
2.1. Acute Kidney Injury Treatment Market Definition
2.2. Product Submarkets Definitions
2.3. Injury Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Acute Kidney Injury Treatment Market Overview
3.1. Global Acute Kidney Injury Treatment Market Size and Forecast by Region
3.2. Global Acute Kidney Injury Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Wider availability of Treatment
3.3.1.2. Increasing the pharmaceutical industry
3.3.1.3. Rapidly increasing health care expenditure
3.3.1.4. Advancement in production techniques
3.3.2. Market Restraints/Challenges
3.3.2.1. High Competition
3.3.2.2. High Cost
3.3.3. Opportunities
3.3.3.1. Promising emerging economies
3.3.3.2. Exploring new disease Injury Types
3.3.4. Global Acute Kidney Injury Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Acute Kidney Injury Treatment Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Dialysis
4.1.1.1. Intermittent Hemodialysis
4.1.1.2. Continuous Renal Replacement Therapy (CRRT)
4.1.1.3. Sustained Low-Efficiency Dialysis (SLED)
4.1.2. Drug Therapy
4.1.2.1. Antibiotics
4.1.2.2. Diuretics
4.1.2.3. Immunosuppressive Agents
5. Global Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 by Injury (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Pre-renal Injury
5.1.2. Intrinsic Renal Injury
5.1.3. Post-renal Injury
5.1.4. Others
6. Global Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospitals
6.1.2. Ambulatory Surgical Centers
6.1.3. Other Distribution Channel
7. North America Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Acute Kidney Injury Treatment Market Size and Forecast by Product
7.3. North America Acute Kidney Injury Treatment Market Size and Forecast by Injury
7.4. North America Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
7.5. U.S. Acute Kidney Injury Treatment Market
7.6. Canada Acute Kidney Injury Treatment Market
8. Europe Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Acute Kidney Injury Treatment Market Size and Forecast by Product
8.3. Europe Acute Kidney Injury Treatment Market Size and Forecast by Injury
8.4. Europe Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
8.5. UK Acute Kidney Injury Treatment Market
8.6. Germany Acute Kidney Injury Treatment Market
8.7. France Acute Kidney Injury Treatment Market
8.8. Rest of Europe Acute Kidney Injury Treatment Market
9. Asia Pacific Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Product
9.3. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Injury
9.4. Asia Pacific Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
9.5. China Acute Kidney Injury Treatment Market
9.6. India Acute Kidney Injury Treatment Market
9.7. Japan Acute Kidney Injury Treatment Market
9.8. Rest of Asia Pacific Acute Kidney Injury Treatment Market
10. Latin America Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Product
10.3. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Injury
10.4. Latin America Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
10.4.1. Brazil Acute Kidney Injury Treatment Market
10.4.2. Mexico Acute Kidney Injury Treatment Market
10.4.3. Rest of Latin America Acute Kidney Injury Treatment Market
11. MEA Acute Kidney Injury Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Acute Kidney Injury Treatment Market Size and Forecast by Product
11.3. MEA Acute Kidney Injury Treatment Market Size and Forecast by Injury
11.4. MEA Acute Kidney Injury Treatment Market Size and Forecast by Distribution Channel
11.5. GCC Acute Kidney Injury Treatment Market
11.6. South Africa Acute Kidney Injury Treatment Market
11.7. Rest of MEA Acute Kidney Injury Treatment Market
12. Companies in the Acute Kidney Injury Treatment Market
12.1. Angion Biomedica Corp
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. AM-Pharma
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Quark Pharmaceuticals, Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Baxter International, Inc.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Fresenius Medical Care AG & Co. KGaA
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. LG Chem Ltd.
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Asahi Kasei Medical Co., Ltd
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. B. Braun Melsungen AG
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Exponential Biotherapies, Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. NIKKISO AMERICA, INC.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Injury
LIST OF TABLES
Table 1 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Acute Kidney Injury Treatment Market Drivers & Restraints 2020
Table 7 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227 Leading 10 Acute Kidney Injury Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 228 Angion Biomedica Corp Profile 2019 (CEO, HQ, Founded, Website)
Table 229 Angion Biomedica Corp Acute Kidney Injury Treatment Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 230 Angion Biomedica Corp Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 231 AM-Pharma Profile 2019 (CEO, HQ, Founded, Website)
Table 232 AM-Pharma Acute Kidney Injury Treatment Selected Recent Contracts 2019 (Date, Contract Product, Details)
Table 233 AM-Pharma Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 234 Quark Pharmaceuticals, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 235 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2017-2019 (Date, Contract Product, Details)
Table 236 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 237 Baxter International, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Baxter International, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 239 Baxter International, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 240 Fresenius Medical Care AG & Co. KGaA Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 242 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 243 LG Chem Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 244 LG Chem Ltd. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 245 LG Chem Ltd. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 246 Asahi Kasei Medical Co., Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 248 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 249 Asahi Kasei Medical Co., Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 250 B. Braun Melsungen AG Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 251 B. Braun Melsungen AG Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 252 Exponential Biotherapies, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Exponential Biotherapies, Inc. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 254 Exponential Biotherapies, Inc. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 255 NIKKISO AMERICA, INC. Profile 2019 (CEO, HQ, Founded, Website)
Table 256 NIKKISO AMERICA, INC. Acute Kidney Injury Treatment Selected Recent Contracts 2015-2019 (Date, Contract Product, Details)
Table 257 NIKKISO AMERICA, INC. Acute Kidney Injury Treatment Product Offering (Segment, Product Offerings)
Table 258 Other Companies Involved in the Acute Kidney Injury Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Acute Kidney Injury Treatment Market Product Overview
Figure 2 Acute Kidney Injury Treatment Market Delivery Mode Overview
Figure 3 Acute Kidney Injury Treatment Market End User Overview
Figure 4 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 Acute Kidney Injury Treatment Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Dialysis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Drug Therapy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Pre-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before
Figure 35 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Intrinsic Renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Post-renal Injury Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Ambulatory Surgical Centers Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Other Distribution Channel Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Regional Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 North America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 North America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 US Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 Canada Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Europe Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Europe Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 UK Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Germany Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 France Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Rest of Europe Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Acute Kidney Injury Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 China Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 India Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 Japan Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 RoAPAC Acute Kidney Injury Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Middle East Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 Middle East Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Latin America Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Latin America Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Africa Acute Kidney Injury Treatment Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Africa Acute Kidney Injury Treatment Market Forecast by Injury 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Acute Kidney Injury Treatment Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Angion Biomedica Corp
2. AM-Pharma
3. Quark Pharmaceuticals, Inc
4. Baxter International, Inc.
5. Fresenius Medical Care AG & Co. KGaA
6. LG Chem Ltd.
7. Asahi Kasei Medical Co., Ltd
8. B. Braun Melsungen AG
9. Exponential Biotherapies, Inc.
10. NIKKISO AMERICA, INC.
11. RenalGuard Solutions, Inc.
12. Thrasos Therapeutics Inc.
13. AtoxBio
14. Sentien Biotechnologies, Inc.
List of Companies Mentioned in the Report:
1. Johnson & Johnson
2. Roche
3. Novartis
4. Sanofi
5. Bayer
6. Merck & Co. (MSD)
7. Eli Lilly
8. Astrazeneca
9. Teva
10. CR Pharmaceutical
11. Bristol-Myers Squibb
12. Merck (KGaA)
13. Novo Nordisk
14. Takeda
15. Allergan
16. Astellas Pharma
17. Mylan
18. Otsuka
19. Daiichi Sankyo
20. Valeant Pharmaceuticals
21. UCB
22. Zoetis
23. Eisai
24. Chugai Pharmaceutical
25. Perrigo
26. Sun Pharmaceutical
27. Mitsubishi Tanabe Pharma
28. Sichuan Languang Development
29. Sumitomo Dainippon Pharma
30. Yunnan Baiyao
31. Aspen Pharmacare
32. Endo
33. Kangmei Pharmaceutical
34. Galenica
35. Guangzhou Baiyunshan Pharmaceutical
36. Kyowa Hakko Kirin
37. Mallinckrodt
38. Shionogi & Co.
39. Shanghai Fosun Pharmaceutical
40. Stada Arzneimittel
41. Lundbeck
42. Zhejiang International
43. Lupin
44. Taisho Pharmaceutical
45. Tasly Pharmaceutical
46. Ipsen
47. Sino Biopharmaceutical
48. Ono Pharmaceutical
49. Aurobindo
50. Cipla
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. Angion Biomedica Corp
2. AM-Pharma
3. Quark Pharmaceuticals, Inc
4. Baxter International, Inc.
5. Fresenius Medical Care AG & Co. KGaA
6. LG Chem Ltd.
7. Asahi Kasei Medical Co., Ltd
8. B. Braun Melsungen AG
9. Exponential Biotherapies, Inc.
10. NIKKISO AMERICA, INC.
11. RenalGuard Solutions, Inc.
12. Thrasos Therapeutics Inc.
13. AtoxBio
14. Sentien Biotechnologies, Inc.
List of Companies Mentioned in the Report:
1. Johnson & Johnson
2. Roche
3. Novartis
4. Sanofi
5. Bayer
6. Merck & Co. (MSD)
7. Eli Lilly
8. Astrazeneca
9. Teva
10. CR Pharmaceutical
11. Bristol-Myers Squibb
12. Merck (KGaA)
13. Novo Nordisk
14. Takeda
15. Allergan
16. Astellas Pharma
17. Mylan
18. Otsuka
19. Daiichi Sankyo
20. Valeant Pharmaceuticals
21. UCB
22. Zoetis
23. Eisai
24. Chugai Pharmaceutical
25. Perrigo
26. Sun Pharmaceutical
27. Mitsubishi Tanabe Pharma
28. Sichuan Languang Development
29. Sumitomo Dainippon Pharma
30. Yunnan Baiyao
31. Aspen Pharmacare
32. Endo
33. Kangmei Pharmaceutical
34. Galenica
35. Guangzhou Baiyunshan Pharmaceutical
36. Kyowa Hakko Kirin
37. Mallinckrodt
38. Shionogi & Co.
39. Shanghai Fosun Pharmaceutical
40. Stada Arzneimittel
41. Lundbeck
42. Zhejiang International
43. Lupin
44. Taisho Pharmaceutical
45. Tasly Pharmaceutical
46. Ipsen
47. Sino Biopharmaceutical
48. Ono Pharmaceutical
49. Aurobindo
50. Cipla
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for Acute Kidney Injury Treatment Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Acute Kidney Injury Treatment Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2023-2033
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
22 May 2023
Visiongain Publishes Dental Consumables Market Report 2023-2033
The global Dental Consumables market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8% from 2023 to 2033.
22 May 2023
